跳至主要内容
临床试验/NCT04811911
NCT04811911Unknown4 期

Evaluation of the Effect of Narrowband Ultraviolet B Versus Methotrexate on Serum TWEAK Level in Psoriasis

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年12月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
30
试验地点
1
主要终点
Serum TWEAK in psoriasis

研究概览

简要总结

The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum TWEAK level in psoriatic patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with moderate to severe plaque psoriasis of any age and gender.

排除标准

  • History of psoriasis treatment with systemic and biological agents prior to the study for at least 3 months.
  • Pregnancy and lactation.
  • Infections
  • Patients with chronic diseases: hepatic disorders, hematologic disease, chronic renal failure or cancer

研究组 & 干预措施

Narrowband ultraviolet B

Active Comparator

Patients will receive 8 sessions of NB-UVB per month for 3 successive months

干预措施: Narrowband ultraviolet B (Radiation)

Methotrexate group

Active Comparator

Patients will receive 25 mg/1ml of methotrexate vial per week for 3 successive months

干预措施: Methotrexate (Drug)

结局指标

主要结局

Serum TWEAK in psoriasis

时间窗: 3 months

Measurement of tumor necrosis factor weak inducer of apoptosis (TWEAK) "pg/ml"; in psoriatic patients before and after treatment with NB-UVB versus MTX in comparison with healthy individuals, using ELISA (enzyme-linked immunosorbent assay).

次要结局

  • Treatment of psoriasis(3 months)

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

El Hassan Mohsen Mansour Mahmoud

Principal investigator

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验